ENOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity

European Journal of Clinical Pharmacology

Volumn 65, Issue 4, 2009, Pages 385-392

  Nagassaki, S ^a   Herculano, R D ^a   Graeff, C F O ^b   Tanus Santos, J E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Endothelial nitric oxide synthase; EPR; Genotypes; Nitric oxide; Polymorphisms; Statins

Indexed keywords

ATORVASTATIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG MECHANISM; ELECTRON SPIN RESONANCE; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ERYTHROCYTE; FEMALE; GENE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MEMBRANE FLUIDITY; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPIN LABELING; TREATMENT DURATION;

ADULT; CHOLESTEROL; CYSTEINE; ELECTRON SPIN RESONANCE SPECTROSCOPY; ERYTHROCYTE MEMBRANE; GENOTYPE; HEMORHEOLOGY; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PYRROLES; THIOBARBITURATES; THREONINE; YOUNG ADULT;

EID: 62549158222     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0602-7     Document Type: Article

References (41)

1. B Lubin F Kuypers D Chiu 1989 Red cell membrane lipid dynamics Prog Clin Biol Res 319 507 522
2. RM Dougherty C Galli A Ferro-Luzzi JM Iacono 1987 Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA Am J Clin Nutr 45 443 455
3. T Macchia R Mancinelli DA Barbini F Taggi U Avico A Cantafora 1991 Determination of membrane cholesterol in normal and pathological red blood cells Clin Chim Acta 199 59 67
4. G Ozdemirler S Kucuk Y Orhan G Aykac-Toker M Uysal 2001 Lipid and protein oxidation in erythrocyte membranes of hypercholesterolemic subjects Clin Biochem 34 335 339
5. M Koter I Franiak K Strychalska M Broncel J Chojnowska-Jezierska 2004 Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia Int J Biochem Cell Biol 36 205 215
6. S Mawatari Y Ohnishi Y Kaji T Maruyama K Murakami K Tsutsui T Fujino 2003 High-cholesterol diets induce changes in lipid composition of rat erythrocyte membrane including decrease in cholesterol, increase in alpha-tocopherol and changes in fatty acids of phospholipids Biosci Biotechnol Biochem 67 1457 1464
7. M Canessa N Adragna HS Solomon TM Connolly DC Tosteson 1980 Increased sodium-lithium countertransport in red cells of patients with essential hypertension N Engl J Med 302 772 776
8. G Zerbini G Ceolotto C Gaboury L Mos AC Pessina M Canessa A Semplicini 1995 Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects Hypertension 25 986 993
9. Y Yamori Y Nara R Horie A Ooshima 1980 Abnormal membrane characteristics of erythrocytes in rat models and men with predisposition to stroke Clin Exp Hypertens 2 1009 1021
10. P Muriel G Sandoval 2000 Nitric oxide and peroxynitrite anion modulate liver plasma membrane fluidity and Na(+)/K(+)-ATPase activity Nitric Oxide 4 333 342
11. K Tsuda K Kimura I Nishio Y Masuyama 2000 Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension: An electron paramagnetic resonance investigation Biochem Biophys Res Commun 275 946 954
12. K Tsuda I Nishio 2004 A calcium channel blocker, benidipine, improves cell membrane fluidity in human subjects via a nitric oxide-dependent mechanism. An electron paramagnetic resonance investigation Am J Hypertens 17 1143 1150
13. BJ Gaffney CM McNamee 1974 Spin-label measurements in membranes. With appendix: a use of computers in EPR spectroscopy Methods Enzymol 32 161 198
14. AS Wierzbicki R Poston A Ferro 2003 The lipid and non-lipid effects of statins Pharmacol Ther 99 95 112
15. W Palinski 2001 New evidence for beneficial effects of statins unrelated to lipid lowering Arterioscler Thromb Vasc Biol 21 3 5
16. M Takemoto JK Liao 2001 Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors Arterioscler Thromb Vasc Biol 21 1712 1719
17. P Dilaveris G Giannopoulos M Riga A Synetos C Stefanadis 2007 Beneficial effects of statins on endothelial dysfunction and vascular stiffness Curr Vasc Pharmacol 5 227 237
18. S Delliaux JG Steinberg G Bechis F Paganelli C Oliver N Lesavre Y Jammes 2007 Statins alter oxidant-antioxidant status and lower exercise-induced oxidative stress Int J Clin Pharmacol Ther 45 244 252
19. JK Liao U Laufs 2005 Pleiotropic effects of statins Annu Rev Pharmacol Toxicol 45 89 118
20. M Martinez A Vaya R Marti L Gil I Lluch R Carmena J Aznar 1996 Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia Haemostasis 26 Suppl 4 171 176
21. S Nagassaki JT Sertorio IF Metzger AF Bem JB Rocha JE Tanus-Santos 2006 eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite Free Radic Biol Med 41 1044 1049
22. C Fatini L Mannini E Sticchi E Cecchi A Bruschettini E Leprini P Pagnini GF Gensini D Prisco R Abbate 2005 eNOS gene affects red cell deformability: role of T-786C, G894T, and 4a/4b polymorphisms Clin Appl Thromb Hemost 11 481 488
23. DC Souza-Costa VC Sandrim LF Lopes RF Gerlach EM Rego JE Tanus-Santos 2007 Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene Atherosclerosis 193 438 444
24. JE Tanus-Santos M Desai DA Flockhart 2001 Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants Pharmacogenetics 11 719 725
25. S Nagassaki IF Metzger DC Souza-Costa AS Marroni JA Uzuelli JE Tanus-Santos 2005 eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population Thromb Res 115 375 379
26. AS Marroni IF Metzger DC Souza-Costa S Nagassaki VC Sandrim RX Correa F Rios-Santos JE Tanus-Santos 2005 Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms Nitric Oxide 12 177 182
27. JE Tanus-Santos M Desai LR Deak JC Pezzullo DR Abernethy DA Flockhart JE Freedman 2002 Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol Pharmacogenetics 12 407 413
28. JT Dodge C Mitchell DJ Hanahan 1963 The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes Arch Biochem Biophys 100 119 130
29. F Rodriguez-Vico M Martinez-Cayuela MF Zafra E Garcia-Peregrin H Ramirez 1991 A procedure for the simultaneous determination of lipid and protein in biomembranes and other biological samples Lipids 26 77 80
30. S Schreier-Muccillo D Marsh IC Smith 1976 Monitoring the permeability profile of lipid membranes with spin probes Arch Biochem Biophys 172 1 11
31. S Schreier CF Polnaszek IC Smith 1978 Spin labels in membranes. Problems in practice Biochim Biophys Acta 515 395 436
32. M Koter M Broncel J Chojnowska-Jezierska K Klikczynska I Franiak 2002 The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia Eur J Clin Pharmacol 58 501 506
33. M Koter I Franiak M Broncel J Chojnowska-Jezierska 2003 Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia Can J Physiol Pharmacol 81 485 492
34. RA Rabini M Polenta R Staffolani M Tocchini R Signore I Testa L Mazzanti 1993 Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes Exp Mol Pathol 59 51 57
35. BC Jubelin JL Gierman 1996 Erythrocytes may synthesize their own nitric oxide Am J Hypertens 9 1214 1219
36. P Kleinbongard R Schulz T Rassaf T Lauer A Dejam T Jax I Kumara P Gharini S Kabanova B Ozuyaman HG Schnurch A Godecke AA Weber M Robenek H Robenek W Bloch P Rosen M Kelm 2006 Red blood cells express a functional endothelial nitric oxide synthase Blood 107 2943 2951
37. U Laufs V La Fata J Plutzky JK Liao 1998 Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1129 1135
38. U Laufs K Gertz P Huang G Nickenig M Bohm U Dirnagl M Endres 2000 Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice Stroke 31 2442 2449
39. U Laufs S Wassmann S Hilgers N Ribaudo M Bohm G Nickenig 2001 Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men Am J Cardiol 88 1306 1307
40. I Pintaric D Eterovic J Tocilj Z Reiner I Lusic 2001 Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia Atherosclerosis 154 493 496
41. M Martinez A Vaya R Marti L Gil I Lluch R Carmena J Aznar 1996 Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin Thromb Res 83 375 388